In patients with confirmed rifampicin-susceptible and isoniazid-resistant tuberculosis, treatment with rifampicin, ethambutol, pyrazinamide and levofloxacin is recommended for a duration of 6 monthsStatusMaintainedRecommended in favorConditionalCertainty of evidenceVery low
In patients with confirmed rifampicin-susceptible and isoniazid-resistant tuberculosis, it is not recommended to add streptomycin or other injectable agents to the treatment regimenStatusMaintainedRecommended againstConditionalCertainty of evidenceVery low